Mutation in SLC6A9 encoding a glycine transporter causes a novel form of non-ketotic hyperglycinemia in humans
Al Qahtani, Hanan
Al Mutairi, Fuad
Al Shaalan, Hesham
Douglas, Ganka V.
Alrifai, Muhammad Talal
Arold, Stefan T.
Abu Ali, Qais
KAUST DepartmentBiological and Environmental Science and Engineering (BESE) Division
Computational Bioscience Research Center (CBRC)
Structural Biology and Engineering
Permanent link to this recordhttp://hdl.handle.net/10754/670030
MetadataShow full item record
AbstractGlycine cleavage system (GCS) catalyzes the degradation of glycine and disruption of its components encoded by GLDC, AMT and GCSH are the only known causes of glycine encephalopathy, also known as non-ketotic hyperglycinemia (NKH). In this report, we describe a consanguineous family with one child who presented with NKH, but harbored no pathogenic variants in any of the three genes linked to this condition. Whole-exome sequencing revealed a novel homozygous missense variant in exon 9 of SLC6A9 NM_201649.3: c.1219 A>G (p.Ser407Gly) that segregates with the disease within the family. This variant replaces the highly conserved S407 in the ion-binding site of this glycine transporter and is predicted to disrupt its function. In murine model, knockout of Slc6a9 is associated with equivalent phenotype of NKH, namely respiratory distress and hypotonia. This is the first demonstration that mutation of the glycine transporter can be associated with NKH in humans.
CitationAlfadhel, M., Nashabat, M., Qahtani, H. A., Alfares, A., Mutairi, F. A., Shaalan, H. A., … Ali, Q. A. (2016). Mutation in SLC6A9 encoding a glycine transporter causes a novel form of non-ketotic hyperglycinemia in humans. Human Genetics, 135(11), 1263–1268. doi:10.1007/s00439-016-1719-x
SponsorsWe wish to thank the family of the patient for their enthusiastic participation. The research by STA reported in this publication was supported by funding from the King Abdullah University of Science and Technology (KAUST).
PublisherSpringer Science and Business Media LLC
PubMed Central IDPMC5052303
Except where otherwise noted, this item's license is described as This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
- Comprehensive mutation analysis of GLDC, AMT, and GCSH in nonketotic hyperglycinemia.
- Authors: Kure S, Kato K, Dinopoulos A, Gail C, DeGrauw TJ, Christodoulou J, Bzduch V, Kalmanchey R, Fekete G, Trojovsky A, Plecko B, Breningstall G, Tohyama J, Aoki Y, Matsubara Y
- Issue date: 2006 Apr
- Identification of the first reported splice site mutation (IVS7-1G-->A) in the aminomethyltransferase (T-protein) gene (AMT) of the glycine cleavage complex in 3 unrelated families with nonketotic hyperglycinemia.
- Authors: Toone JR, Applegarth DA, Coulter-Mackie MB, James ER
- Issue date: 2001
- d-Glyceric aciduria does not cause nonketotic hyperglycinemia: A historic co-occurrence.
- Authors: Swanson MA, Garcia SM, Spector E, Kronquist K, Creadon-Swindell G, Walter M, Christensen E, Van Hove JLK, Sass JO
- Issue date: 2017 Jun
- A novel compound heterozygous variant identified in GLDC gene in a Chinese family with non-ketotic hyperglycinemia.
- Authors: Lin Y, Zheng Z, Sun W, Fu Q
- Issue date: 2018 Jan 5
- Treatment from birth of nonketotic hyperglycinemia due to a novel GLDC mutation.
- Authors: Korman SH, Wexler ID, Gutman A, Rolland MO, Kanno J, Kure S
- Issue date: 2006 Feb